Porton Pharma Solutions Ltd. (SZSE: 300363)
Health Care · Pharmaceuticals · CN
CN¥23.68
-3.58% today · +1.5% 1Y
Porton Pharma Solutions Ltd. (SZSE: 300363) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.90B and employs 4,359 people.
Over the last twelve months the share price has gained 1.5%, trading between 13.24 and 30.40.
Tweenvest scores Porton Pharma Solutions Ltd. across four factors: quality 70/100, value 44/100, growth 79/100, dividend 25/100. Its strongest factor is growth.
300363 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.90B
- Revenue (TTM)
- $528.32M
- P/E
- —
- EPS
- -0.29
- Dividend yield
- 0.38%
- Beta (5Y)
- 0.55
- 52-week high
- CN¥30.40
- 52-week low
- CN¥13.24
- Avg volume (3M)
- —
- Shares outstanding
- 536.27M
- Employees
- 4,359
- Next earnings
- —
About Porton Pharma Solutions Ltd.
Porton Pharma Solutions Ltd. caters to pharmaceutical companies by manufacturing and supplying a diverse portfolio of products, which encompasses small molecule active pharmaceutical ingredients (APIs), drug intermediates, various dosage forms, and biologics. The company was formerly known as Porton Fine Chemicals Ltd. until it adopted its current name in January 2018. Established in 2005, Porton Pharma Solutions Ltd. operates from its headquarters in Chongqing, China.
- ISIN
- CNE100001S57
- Founded
- 2005
- Listed since
- Jan 29, 2014
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd.SZSE: 002399 | $1.95B | CN¥9.89 | +0.41% |
| Caplin Point Laboratories LimitedBSE: 524742 | $1.93B | Rs2,459.55 | -6.56% |
| Xeris Biopharma Holdings, Inc.NasdaqGS: XERS | $1.91B | $10.48 | +2.85% |
| Shenyang Xingqi Pharmaceutical Co.,Ltd.SZSE: 300573 | $1.90B | CN¥35.55 | -0.31% |
| The United Laboratories International Holdings LimitedSEHK: 3933 | $1.89B | HK$7.52 | +0.07% |
| Trevi Therapeutics, Inc.NasdaqGM: TRVI | $1.88B | $13.19 | +2.85% |
| Beijing Aosaikang Pharmaceutical Co., Ltd.SZSE: 002755 | $1.85B | CN¥13.34 | -1.55% |
| Structure Therapeutics Inc.NasdaqGM: GPCR | $1.82B | $25.54 | -7.70% |
Figures last refreshed Oct 11, 2026.